Literature DB >> 6969941

Antigen-pulsed neutrophils bearing Ia antigens can induce T lymphocyte proliferative response to the syngeneic or semisyngeneic antigen-primed T lymphocytes.

K Okuda, K Tani, Y Ishigatsubo, S Yokota, C S David.   

Abstract

Antigen-pulsed neutrophils from mouse peritoneal cavities displayed a remarkable level of lymphocyte proliferative activities to antigen-primed T lymphocytes. Genetic mapping studies demonstrated that compatibility at the I-A, as well as I-E/C, subregions of the major histocompatibility complex (MHC) was essential for effective presentation of the lysozyme antigen. These antigen-presenting activities were remarkably inhibited by anti-Ia sera. Inhibition tests revealed that neutrophil immune-associated (Ia) antigens seem to be essential for antigen presentation during the initial 8 hr. Elimination studies of antigen-pulsed neutrophils with alloantisera plus complement revealed these antigen-presenting neutrophils bearing both I-A and I-E/C gene products on the same cells. These results suggest that Ia-positive neutrophils might play a role in the immune response through antigen presentation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6969941     DOI: 10.1097/00007890-198011000-00012

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  11 in total

1.  Induction of lymphocyte proliferation by antigen-pulsed human neutrophils.

Authors:  C Prior; P J Townsend; D A Hughes; P L Haslam
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

2.  Granulocyte precursors are the principal cells in bone marrow that stimulate allospecific cytolytic T-lymphocyte responses.

Authors:  A A Czitrom; T S Axelrod; B Fernandes
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

3.  The effect of adjuvants and prior immunization on the rate and mode of uptake of antigen into afferent popliteal lymph from sheep.

Authors:  K J Beh; A K Lascelles
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

4.  Antigen presentation to human T lymphocytes. I. Different requirements for stimulation by hapten-modified cells vs. cell sonicates.

Authors:  S L Abramson; J M Puck; R R Rich
Journal:  J Exp Med       Date:  1981-10-01       Impact factor: 14.307

5.  ICAM1+ neutrophils promote chronic inflammation via ASPRV1 in B cell-dependent autoimmune encephalomyelitis.

Authors:  Ryder F Whittaker Hawkins; Alexandre Patenaude; Aline Dumas; Rajiv Jain; Yodit Tesfagiorgis; Steven Kerfoot; Takeshi Matsui; Matthias Gunzer; Patrice E Poubelle; Catherine Larochelle; Martin Pelletier; Luc Vallières
Journal:  JCI Insight       Date:  2017-12-07

6.  Effects of supernatants of polymorphonuclear neutrophils recruited by different inflammatory substances on mitogen responses of lymphocytes.

Authors:  M L Rodrick; I B Lamster; S T Sonis; S G Pender; A B Kolodkin; J E Fitzgerald; R E Wilson
Journal:  Inflammation       Date:  1982-03       Impact factor: 4.092

7.  Role of macrophages in the lymphocyte response to Actinomyces viscosus.

Authors:  R M McCarron; J E Fitzgerald; D C Birdsell
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

8.  Inflammatory and immunological responses in skin and peripheral lymph of sheep following intracutaneous injection of Staphylococcus aureus.

Authors:  R L Kerlin; D L Watson; I G Colditz
Journal:  Inflammation       Date:  1987-06       Impact factor: 4.092

9.  Interaction of Ia antigen-bearing polymorphonuclear leukocytes and murine splenocytes.

Authors:  J E Fitzgerald; S T Sonis; M L Rodrick; R E Wilson
Journal:  Inflammation       Date:  1983-03       Impact factor: 4.092

10.  Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma.

Authors:  A Stoppacciaro; C Melani; M Parenza; A Mastracchio; C Bassi; C Baroni; G Parmiani; M P Colombo
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.